Recently diagnosed with Small-Cell Lung Cancer?

NORTH Small-cell Lung Cancer Clinical Trial - Doctor & Patient

The NORTH clinical study is designed to assess the effect of adding an investigational antibody-drug conjugate to a standard-of-care treatment for newly diagnosed small-cell lung cancer. It is being conducted by ImmunoGen, Inc., whose technology is used in Kadcyla (formerly T-DM1).